NMPA Approval

Moxifloxacin Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20244974

Company河北天成药业股份有限公司

Registration Date

September 26, 2024

Drug Information

Generic Name

盐酸莫西沙星氯化钠注射液

Dosage Form

注射剂

Strength

250ml：盐酸莫西沙星（按C₂₁H₂₄FN₃O₄计）0.4g与氯化钠2.0g

Drug Type

化学药品

Registration Date

September 26, 2024

Company Information

Applicant Company

Company Name河北天成药业股份有限公司

Company Address

沧州经济技术开发区金光大街18号

Manufacturing Company

Company Name河北天成药业股份有限公司

Company Address

沧州经济技术开发区金光大街18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星氯化钠注射液 - NMPA 批准文号 | MedPath